ETELCALCETIDE injection (Parsabiv)
Clinical Indication
Secondary hyperparathyroidism in adult patients with chronic kidney disease on haemodialysis therapy
Comments
Inline with NICE TA 448
Date of classification
March 2017
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.